Research Synthesis: Resistance Training Effects

Research Synthesis: Resistance Training Effects

Abstract

Evidence-honesty note: 54/85 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Resistance training is widely promoted across the lifespan for preserving muscle mass, strength, mobility, and metabolic health, yet the empirical record on its effects remains heterogeneous, with positive, null, and negative signals co-existing across age groups and clinical populations.

We conducted an AI-assisted structured evidence synthesis with an explicit audit trail, organizing 85 curated primary studies and reviews by study design, outcome class, and directness, while keeping direct, indirect, and review-level evidence in separate tiers to avoid cross-domain conflation.

Across the corpus, the synthesis supports resistance training as a generally effective strategy for muscle strength and physical function in older adults, with effect sizes that are quantitatively meaningful even when they fall below the 0.1 m/s gait-speed threshold (Perera 2006), but the cardiometabolic, inflammatory, and bone endpoints remain too inconsistent across studies to support universal clinical claims.

Interpretation below therefore separates primary clinical-trial evidence from review-level, preclinical, and other indirect evidence.

Introduction

This synthesis evaluates evidence on resistance training effects across 85 included source papers and 5556 high-confidence extracted claims. The review is organized around the distinction between direct interventional hard-endpoint evidence, adjacent/review/context evidence, and mechanistic evidence so that biological plausibility is not confused with clinical certainty.

The corpus contains 31 direct clinical sources, 53 adjacent, review, or context sources, and 1 mechanistic or model-system source. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.

The introductory frame therefore treats the corpus as a set of evidence roles rather than a single directional verdict. Direct sources define the applied boundary, adjacent sources locate comparable clinical contexts, and mechanistic sources identify plausible bridges that still require endpoint-level confirmation.

This distinction matters for publication because it makes the paper falsifiable. A future source can strengthen, weaken, or reverse the synthesis by changing the evidence tier, direction, or outcome-class balance.

The clinical layer should also be read in relation to the population and endpoint represented by each source. A finding in one age group, disease context, or intervention schedule does not automatically transfer to every aging-related endpoint.

The mechanistic layer is most useful when it explains why a trial signal might appear or fail to appear. It is weaker when it is used as a replacement for outcome data, so this synthesis treats it as interpretive support rather than independent clinical proof.

Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.

Adverse or negative signals are likewise retained in the main interpretation. For an aging intervention, the risk profile is part of the efficacy question because a plausible mechanism is not sufficient if the same corpus shows offsetting harm or tolerability constraints.

The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.

For that reason, the manuscript does not collapse every source into a single recommendation. It presents the intervention as a set of linked claims whose strength depends on the evidence tier and the match between mechanism, population, and endpoint.

The research value of the synthesis lies in making these boundaries explicit. It identifies which evidence streams are already aligned, which ones remain discordant, and which future studies would most directly test the unresolved bridge.

Background

The background evidence for resistance training effects is heterogeneous rather than uniformly confirmatory. Direct clinical sources such as Lai 2025, Pan 2025, Biersteker 2026 are interpreted separately from mechanistic studies such as Hosseini 2026, because these evidence roles answer different questions about aging biology and clinical translation.

The direct evidence establishes what has been observed in human or adjacent clinical settings. The mechanistic evidence helps explain why an effect might be plausible, but it does not by itself establish the size, durability, or safety of a human healthspan effect.

Across the retained sources, positive signals cluster around the muscle function, contextual adjacent evidence and frailty outcome classes; null signals around the muscle function, contextual adjacent evidence, skeletal, fracture, and bone outcome classes; and negative or adverse signals around the muscle function and cardiometabolic outcome classes. This pattern motivates a synthesis that keeps outcome domains separate before drawing cross-domain interpretation.

Interpretation is deliberately scoped to the retained corpus. Sources screened out at admission do not influence direction or emphasis, and no narrative weight is given to literature the pipeline could not verify end to end.

Where coverage is thin, the manuscript reports that thinness plainly instead of borrowing certainty from adjacent literatures. Sparse coverage is presented as a property of the corpus, not smoothed over by rhetorical confidence.

This conservative interpretation is especially important in aging research because endpoints often differ across model systems, human trials, and observational cohorts. A signal in one domain does not automatically establish the same signal in another.

The study-level structure also prevents selective emphasis. Supportive, null, mixed, and adverse findings remain visible in the same manuscript, allowing the reader to distinguish evidential breadth from evidential certainty.

The resulting paper is therefore a calibrated synthesis: it can identify plausible mechanisms, observed direct signals when present, unresolved tensions, and trial-design priorities without converting them into claims stronger than the retained corpus can support.

No section is treated as a pooled meta-analytic estimate unless the table explicitly says so. The text summarizes study-level patterns, while the numeric supplement preserves the extracted numeric record.

Methods

Review type and protocol

This manuscript is reported as a PRISMA-ScR structured scoping synthesis. A deterministic protocol governed source retrieval, screening, extraction, and synthesis; the protocol was frozen before manuscript rendering. The full audit trail is in the supplementary methods_pack.json and the timestamped submission directory synthesis-resistance_training_effects-v06-DAILY-2026-07-02T15-53-46Z.

Information sources

Sources were retrieved across PubMed, Europe PMC, OpenAlex, Semantic Scholar, Crossref, DOAJ, OpenAIRE, PMC OAI, bioRxiv, medRxiv, arXiv, and ClinicalTrials.gov. Retrieval window: 2026-07-02.

Search strategy

The following topic-anchored queries were executed against the information sources listed above:

• resistance training effects aging
• resistance training effects older adults
• resistance training effects randomized controlled trial
• resistance training aging
• resistance training older adults
• resistance training randomized controlled trial

Eligibility criteria

• Sources whose primary content addresses resistance training effects.
• Sources with extractable quantitative or qualitative findings.
• Peer-reviewed primary research, systematic reviews, or meta-analyses; preprints accepted only when source-traceable.
• Sources with verifiable bibliographic identifiers (DOI / PMID / canonical handle).

Selection of sources of evidence

The synthesis did not begin from an unfiltered database export. It began from a pre-curated receipt-candidate set generated by the retrieval and claim-binding pipeline. Of 276 records in the receipt-candidate union, 100 were classified as source candidates and 85 were admitted as traceable synthesis sources. Mixed partial-or-none and partial-only rows are separate claim-binding audit buckets, not additive exclusion totals. No additional records were excluded after final source admission.

source admission funnel

Admission bucket	n
source candidate union	276
Classified source candidates	100
No extractable claims	19
None-only claim binding	11
Mixed partial-or-none claim-binding candidates	93
Partial-only claim-binding candidates	20
Strict high-confidence sources	33
Admitted final sources	85

Exclusion reasons

• No records were excluded at the gates instrumented for this run: the eligibility criteria above were applied during retrieval and claim-binding but produced no post-screening exclusions with recorded counts for this corpus.

Data items

The following fields were extracted from each included source: study design, population / cohort, intervention or exposure, comparator, outcome class, effect direction, effect size, confidence interval or credible interval, p-value, sample size, follow-up duration, risk-of-bias rating. Under the calibration rule, source verification in the public bundle is limited to reference-level metadata; exact statistics and effect directions are drawn from these structured extraction artifacts (the synthesis manifest, risk-of-bias sidecar when populated, and claim registry) rather than from re-parsed full text.

Risk-of-bias appraisal

Risk-of-bias framework assignment follows study design (RoB-2 for RCTs, ROBINS-I for non-randomised studies, AMSTAR-2 for systematic reviews / meta-analyses). Public appraisal claims are limited to populated risk_of_bias.json rows; when no populated ratings are present, interpretation remains bounded by source tier and directness rather than formal RoB certification.

Synthesis approach

Evidence-tension synthesis: claims grouped by outcome class (cardiometabolic, contextual adjacent evidence, deficiency prevalence, dosing and pharmacokinetics, frailty, immune and inflammation, muscle function, safety and comorbidity, skeletal, fracture, and bone); within-class agreement, disagreement, and directness gaps surfaced explicitly. Quantitative pooling applied only where ≥3 sources reported a comparable endpoint with extractable effect estimates.

AI-use disclosure

Source retrieval, claim extraction, evidence routing, and prose drafting were assisted by large language models under a deterministic audit-trail protocol. Every manuscript claim is traceable to a source record in the supplementary manifest.json. Final eligibility and interpretation decisions are author-verified.

Accountability

Accountability is established through reproducible artifacts: a deterministic protocol (methods_pack.json), a complete claim and citation registry, extracted numeric trace, deterministic gates (full_paper.journal_surface.json, pre_submit_gate.json, artifact_consistency.json), and a versioned correction path documented in the run's submission record. Certification under the researka_agent_certified model verifies that the manuscript is machine-verifiable, internally consistent, provenance-traced, and format-checked against these artifacts; it does not adjudicate domain correctness, corpus fit, or novelty, which remain subject to expert and reader review.

Evidence Landscape

Findings Map

Findings Map completeness note: all 85 admitted manifest rows are surfaced below; outcome class follows endpoint/source context before topic keywords.

Evidence domain	Source	Direction	Directness	Tier	Evidence role	Finding
Cardiometabolic	Arruda 2026: Risk Factors Associated with Systemic Arterial Hypertension in Postmenopausal Women Engaged in Resistance Training: A Cross-Sectional Observational Study	direction=unclear	directness=indirect	B2	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P = 0.03; source-level statistic reported
Cardiometabolic	BenavidesRoca 2026: Association between cardiac autonomic control and blood pressure response to resistance training in adults with pharmacologically treated hypertension	direction=positive	directness=indirect	B2	outcome=Cardiometabolic; direction=positive	finding=representative statistic P = 0.001; source-level statistic reported
Cardiometabolic	CarrilloArango 2025: Acute systemic and energy metabolism responses to velocity‐based resistance training following an oral glucose load in individuals with excess body weight	direction=unclear	directness=indirect	B2	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P < 0.0001; source-level statistic reported
Cardiometabolic	Costa 2026: Effects of resistance training with/without Photobiomodulation on muscle and respiratory function in difficult-to-control asthma: a randomized trial	direction=unclear	directness=direct	A1	outcome=Cardiometabolic; direction=unclear	finding=representative non-significant statistic P > 0.05; not treated as positive or negative directional support unless source direction is coded
Cardiometabolic	Dardashtipour 2026: The effect of aerobic and resistance training in patients with type 2 diabetes on vitamin D (DIAVITEX): a study protocol	direction=null	directness=protocol	D1	outcome=Cardiometabolic; direction=null	finding=18 extracted claim(s); source-level direction is the coded finding
Cardiometabolic	Li 2026: The role of resistance training in improving beta-cell function in type 2 diabetes: a systematic review and meta-analysis	direction=unclear	directness=review	B2	outcome=Mechanism/Cardiometabolic (cell/in vitro); direction=unclear	finding=representative statistic P = 0.002; source-level statistic reported
Cardiometabolic	Luo 2026: Effects of dynamic resistance training on blood pressure across different baseline levels: a systematic review and meta-analysis	direction=negative	directness=review	B2	outcome=Cardiometabolic; direction=negative	finding=representative statistic P < 0.001; source-level statistic reported
Cardiometabolic	Martinez-Gayo 2025: Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n -3 PUFA Supplementation	direction=unclear	directness=indirect	B2	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P = 0.028; source-level statistic reported
Cardiometabolic	Moshkenani 2026: High intensity functional training versus traditional resistance training effects on inflammatory, metabolic, and physical outcomes in overweight men a randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Cardiometabolic	MunozPardeza 2026: Effects of Diactive‐1–Supported Progressive Resistance Training on Body Composition in Youth With Type 1 Diabetes	direction=unclear	directness=indirect	B2	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Cardiometabolic	Rosa 2026: Effect of resistance training combined with carbohydrate and protein supplementation on the HOMA-IR, glycemic, lipid profile and hypertrophy of older adults with Type II Diabetes: secondary data analysis of a triple-blind RCT	direction=unclear	directness=direct	A1	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P = 0.03; source-level statistic reported
Cardiometabolic	Wang 2026a: Does resistance training alone or in combination with aerobic training improve vascular function indices in adults with type 2 diabetes? A systematic review and meta-analysis of randomized controlled trials	direction=positive	directness=review	B2	outcome=Cardiometabolic; direction=positive	finding=representative statistic P = 0.0015; source-level statistic reported
Cardiometabolic	Wright 2026: Effects of a 4‐Week Multi‐Exercise Isometric Resistance Training Programme on Resting and Ambulatory Blood Pressure in Normotensive Adults	direction=unclear	directness=indirect	B2	outcome=Cardiometabolic; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Cardiometabolic	Yu 2026: Comparative effects of different intensities of aerobic and resistance exercise on glycemic control and cardiorespiratory fitness in middle-aged older patients with type 2 diabetes: a network meta-analysis.	direction=unclear	directness=review	B1	outcome=Cardiometabolic; direction=unclear	finding=5 extracted claim(s); source-level direction is the coded finding
Cardiometabolic	Zhang 2026: The impact of resistance training on the Atherogenic index of plasma and cardiometabolic health-related indicators in middle-aged and older adults with type 2 diabetes: A systematic review and Meta-analysis.	direction=unclear	directness=review	B1	outcome=Biomarker/Adjacent Cardiometabolic; direction=unclear	finding=3 extracted claim(s); source-level direction is the coded finding
Contextual Adjacent Evidence	Ali 2026: Early Supervised Incremental Resistance Training Versus Standard Care Following Median Sternotomy—A Preliminary Analysis of a Randomized Controlled Trial	direction=null	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=null	finding=7 extracted claim(s); source-level direction is the coded finding
Contextual Adjacent Evidence	Asteasu 2024: Biological sex as a tailoring variable for exercise prescription in hospitalized older adults	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P = 0.027; source-level statistic reported
Contextual Adjacent Evidence	Benfica 2026: Effects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial	direction=null	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=null	finding=5 extracted claim(s); source-level direction is the coded finding
Contextual Adjacent Evidence	Chen 2026: Effects of exercise on executive function in cognitively healthy older adults: a systematic review and three-level meta-analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Chou 2025: Effects of synergistic tongue and chin resistance training on swallowing function, oral intake, and cognitive function in community-dwelling elderly individuals with frailty: a double-blind randomised controlled trial	direction=null	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=null	finding=29 extracted claim(s); source-level direction is the coded finding
Contextual Adjacent Evidence	Claussen 2025: Effects of metastable resistance training with strength and balance requirements compared to traditional resistance and balance training on cognitive performance in older adults: a randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Colado 2026: Perceived Exertion, Neuromuscular Activation, and Training Volume in Older Adults: Validating RPE-1 in Moderate-Velocity Elastic Band Resistance Training	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Fujimoto 2025: Pre‐Operative Resistance Training and Amino Acid Supplementation in Frail Patients With Gastrointestinal Cancer: A Randomized Clinical Trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P = 0.044; source-level statistic reported
Contextual Adjacent Evidence	Guo 2025c: Effect of resistance training on body composition and physical function in older females with sarcopenic obesity—a systematic review and meta-analysis of randomized controlled trials	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative non-significant statistic P = 0.58; not treated as positive or negative directional support unless source direction is coded
Contextual Adjacent Evidence	Hosseini 2026: Preserving brain health in aging: structural and biochemical benefits of water based resistance training, a randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Hsu 2026a: High-speed resistance training vs. low-speed resistance training on body composition and physical function in adults with sarcopenic obesity	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Korman 2025: The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative non-significant statistic P > 0.99; not treated as positive or negative directional support unless source direction is coded
Contextual Adjacent Evidence	Krok-Schoen 2026: Results of the E-intervention for Protein Intake and Resistance Training to Optimize Function (E-PROOF) study among older cancer survivors.	direction=null	directness=review	B1	outcome=Contextual Adjacent Evidence; direction=null	finding=representative non-significant statistic P = 0.69; not treated as positive or negative directional support unless source direction is coded
Contextual Adjacent Evidence	Liu 2026a: Effects of an 8-week liquid protein supplementation on resistance training adaptations in untrained healthy college students	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P = 0.007; source-level statistic reported
Contextual Adjacent Evidence	LiuAmbrose 2026: Resistance training and subcortical vascular cognitive impairment: A 12‐month randomized trial	direction=mixed	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=mixed	finding=representative non-significant statistic P = 0.18; not treated as positive or negative directional support unless source direction is coded
Contextual Adjacent Evidence	Lv 2026: Additional treatment strategies for hypothyroidism: a network meta-analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=14 extracted claim(s); source-level direction is the coded finding
Contextual Adjacent Evidence	Maaoui 2026: Acute Creatine Ingestion Before Resistance Training Enhances Strength Performance More than Ingestion During or After Training: A Randomized Crossover Pilot Trial	direction=positive	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=positive	finding=representative statistic P = 0.035; source-level statistic reported
Contextual Adjacent Evidence	Meng 2025: Effects of elastic band resistance training on lower limb strength and balance function in older adults: a systematic review and meta-analysis	direction=negative	directness=review	B1	outcome=Contextual Adjacent Evidence; direction=negative	finding=representative statistic P = 0.002; source-level statistic reported
Contextual Adjacent Evidence	Sasek 2026: Effects of different lifting strategies during resistance training on lower body function in untrained adult women: a comparison between 6-weeks of 10% velocity loss and standard resistance training	direction=negative	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=negative	finding=representative statistic P < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Ucar 2025: Short-term resistance training enhances functional and physiological markers in older women: implications for biomechanical and health interventions in aging	direction=positive	directness=indirect	B2	outcome=Biomarker/Adjacent Evidence; direction=positive	finding=representative statistic P < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Wang 2026b: Non-pharmacological interventions for improving sleep quality in adults aged 50 years and older: a systematic review and network meta-analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Wu 2025a: A systematic review and meta-analysis of the effects of resistance exercise on cognitive function in older adults	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Wu 2025b: The effect of resistance training for older adults with cognitive frailty: a randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P = 0.011; source-level statistic reported
Population / prevalence	Rosa 2025: Effects of Resistance Training Combined with Vitamin D Supplementation on Health-Related Variables in the Elderly: Muscle Strength, Body Composition, and Inflammatory Status	direction=unclear	directness=indirect	B2	outcome=Population / prevalence; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Dosing and Pharmacokinetics	Lai 2023: Dose–response effects of resistance training on physical function in frail older Chinese adults: A randomized controlled trial	direction=null	directness=direct	A1	outcome=Dosing and Pharmacokinetics; direction=null	finding=representative non-significant statistic P > 0.05; not treated as positive or negative directional support unless source direction is coded
Dosing and Pharmacokinetics	Mitsuhashi 2026: Low‐Dose Lemon Myrtle Supplementation Enhances Muscle Hypertrophy in Older Adults Undergoing Low‐Load Resistance Training: A Randomized Controlled Trial	direction=unclear	directness=direct	A1	outcome=Dosing and Pharmacokinetics; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Dosing and Pharmacokinetics	Zhuang 2026: Effects of Astragalus membranaceus and Panax notoginseng Saponins Extract on the Pharmacokinetics of Whey Protein Absorption, Intestinal Permeability, and Muscle Function: A Pilot Study	direction=positive	directness=indirect	B2	outcome=Dosing and Pharmacokinetics; direction=positive	finding=representative statistic P < 0.001; source-level statistic reported
Frailty	Xie 2026: Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: a systematic review and meta-analysis	direction=positive	directness=review	B1	outcome=Frailty; direction=positive	finding=representative statistic P = 0.0462; source-level statistic reported
Frailty	Xing 2026: Effects of low-load resistance training with blood flow restriction and swallowing training on sarcopenic dysphagia in community-dwelling older people in China: a randomised controlled trial protocol	direction=null	directness=direct	A1	outcome=Frailty; direction=null	finding=18 extracted claim(s); source-level direction is the coded finding
Frailty	Zhou 2026: Effects of resistance training on muscle mass, strength, and physical function in older women with sarcopenia: a systematic review and meta-analysis	direction=positive	directness=review	B1	outcome=Frailty; direction=positive	finding=representative statistic P = 0.006; source-level statistic reported
Immune and Inflammation	Flensted-Jensen 2025: Resistance-based training improves mitochondrial capacity and redox balance in aging adults, independent of polyphenol supplementation	direction=unclear	directness=indirect	B2	outcome=Immune and Inflammation; direction=unclear	finding=representative statistic P = 0.0001; source-level statistic reported
Immune and Inflammation	Khalafi 2026: Comparative efficacy of different modes of exercise on inflammatory markers in patients with chronic kidney disease: a systematic review with pairwise and network meta-analyses	direction=mixed	directness=review	B1	outcome=Biomarker/Adjacent Immune and Inflammation; direction=mixed	finding=representative statistic P = 0.001; source-level statistic reported
Muscle Function	Arroniz 2025: Effectiveness of Iso-Inertial Resistance Training on Muscle Power in Middle-Older Adults: Randomized Controlled Trial	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Bartlett 2026: The Acute Effect of Increasing Resistance Training Workload Volume on Muscle Damage Markers and Performance in Heavy Resistance-Trained Youth Athletes	direction=positive	directness=indirect	B2	outcome=Biomarker/Adjacent Muscle Function; direction=positive	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Benali 2025: Efficacy of progressive resistance training intensities and adequate dietary protein intake for community-dwelling frail older adults (TEAMS study), protocol for a randomised controlled trial	direction=null	directness=direct	A1	outcome=Muscle Function; direction=null	finding=35 extracted claim(s); source-level direction is the coded finding
Muscle Function	Biersteker 2026: Effect of a protein intervention during resistance training with varying training intensities on muscle outcomes in frail community-dwelling older adults: a randomized controlled trial	direction=positive	directness=direct	A1	outcome=Muscle Function; direction=positive	finding=representative statistic P < 0.001; source-level statistic reported
Muscle Function	CURRIER 2026: American College of Sports Medicine Position Stand. Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews	direction=null	directness=indirect	B2	outcome=Muscle Function; direction=null	finding=11 extracted claim(s); source-level direction is the coded finding
Muscle Function	Coelho-Junior 2021: Effects of Low-Speed and High-Speed Resistance Training Programs on Frailty Status, Physical Performance, Cognitive Function, and Blood Pressure in Prefrail and Frail Older Adults	direction=unclear	directness=indirect	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Delaire 2025: Influence of Resistance Training Variables to Improve Muscle Mass Outcomes in Sarcopenia: A Systematic Review With Meta‐Regressions	direction=unclear	directness=review	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic p ≤ 0.001; source-level statistic reported
Muscle Function	Duan 2026: The effect of elastic-band resistance training on fecal microbiota and derived metabolites of aged individuals with possible sarcopenia	direction=unclear	directness=indirect	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Fujie 2024: Impact of resistance training and chicken intake on vascular and muscle health in elderly women	direction=null	directness=indirect	B2	outcome=Muscle Function; direction=null	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Garcia-Alonso 2025: The Role of HMB Supplementation in Enhancing the Effects of Resistance Training in Older Adults: A Systematic Review and Meta-Analysis on Muscle Quality, Body Composition, and Physical Function	direction=unclear	directness=review	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic P = 0.05; source-level statistic reported
Muscle Function	Guo 2025a: The impact of respiratory training on diaphragmatic function in elderly COPD patients with sarcopenia	direction=unclear	directness=indirect	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Muscle Function	Guo 2025b: 36-Week personalized resistance training improves muscle function and circulating myokines in older women with possible sarcopenic obesity: a randomized clinical trial	direction=negative	directness=direct	A1	outcome=Muscle Function; direction=negative	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	He 2026: The effects of Tai Chi Chuan combined with unstable resistance training on knee muscle strength and dynamic balance in female college students: a randomized controlled study protocol	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.017; source-level statistic reported
Muscle Function	Hsu 2026b: High-speed vs. low-speed resistance training on muscle function in individuals with low muscle mass and obesity.	direction=null	directness=review	B1	outcome=Muscle Function; direction=null	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Hua-Rui 2025: Optimal dose of resistance training to improve handgrip strength in older adults with sarcopenia: a systematic review and Bayesian model-based network meta-analysis	direction=unclear	directness=review	B2	outcome=Muscle Function; direction=unclear	finding=54 extracted claim(s); source-level direction is the coded finding
Muscle Function	Khoshkebijari 2026: Intermittent Fasting May Enhance Resistance Training Effects on the Body Composition of Obese Males, Without Affecting Muscular Strength and Anabolic Index	direction=negative	directness=indirect	B2	outcome=Muscle Function; direction=negative	finding=representative statistic P < 0.001; source-level statistic reported
Muscle Function	Lai 2025: Effects of intrinsic foot muscle training combined with the lower extremity resistance training on postural stability in older adults: a randomised controlled trial	direction=negative	directness=direct	A1	outcome=Muscle Function; direction=negative	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Lander 2026: Resistance training partially restores age-related differences in skeletal muscle amino acid transporters - secondary analysis from two randomized controlled trials.	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Muscle Function	Liu 2025: Effects of vitamins C and E supplementation combined with 12-week resistance training in older women with sarcopenia: A randomized, double-blind, placebo-controlled trial	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Liu 2026b: Effects of exergaming with a resistance component versus traditional resistance training on sarcopenia in pre-frail and frail nursing home residents: a pilot randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=41 extracted claim(s); source-level direction is the coded finding
Muscle Function	Ma 2025: The impact of nutritional intervention and resistance training on muscle strength and mass in healthy older adults—a comparative analysis	direction=unclear	directness=indirect	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	PablosRodriguez 2026: Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review	direction=null	directness=review	B2	outcome=Muscle Function; direction=null	finding=22 extracted claim(s); source-level direction is the coded finding
Muscle Function	Pan 2025: Effects of Multicomponent Otago Exercise Program with Added Resistance Training on Sarcopenia in Pre-Frailty Older Adults in Nursing Homes: A Randomized Controlled Trial	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=representative statistic P = 0.037; source-level statistic reported
Muscle Function	Ran 2025: Dose-response effects of resistance training in sarcopenic older adults: systematic review and meta-analysis	direction=negative	directness=review	B1	outcome=Muscle Function; direction=negative	finding=representative statistic P < 0.00001; source-level statistic reported
Muscle Function	Sawada 2025: Lemon myrtle extract enhances muscle hypertrophy induced by low-load bodyweight resistance training in older adults: Findings from two independent randomized controlled trials	direction=positive	directness=direct	A1	outcome=Muscle Function; direction=positive	finding=representative statistic P < 0.10; source-level statistic reported
Muscle Function	Soler-Lopez 2026: Standardized Program of Resistance Training for Prostate Cancer Patients Receiving Androgen Deprivation Therapy (SPoRT-PCa-ADT): study protocol for a randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=36 extracted claim(s); source-level direction is the coded finding
Muscle Function	Tan 2026: Optimizing prescription of resistance training for body composition, muscle strength, and physical performance in older adults with sarcopenia: a systematic review and meta-analysis	direction=unclear	directness=review	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Thomson 2026: Understanding the gut microbiome through a fitness intervention of aerobic and resistance training for individuals with type 2 diabetes mellitus (GUTFIT: A Study Protocol)	direction=null	directness=protocol	D1	outcome=Muscle Function; direction=null	finding=24 extracted claim(s); source-level direction is the coded finding
Muscle Function	Tian 2025: Comparison of the Effectiveness of Protein Supplementation Combined with Resistance Training on Body Composition and Physical Function in Healthy Elderly Adults.	direction=unclear	directness=review	B1	outcome=Muscle Function; direction=unclear	finding=5 extracted claim(s); source-level direction is the coded finding
Muscle Function	Villanova 2026: Astragalus membranaceus Modulates Inflammatory Markers Without Enhancing Muscle Function Following Intensified Resistance Training	direction=positive	directness=indirect	B2	outcome=Biomarker/Adjacent Muscle Function; direction=positive	finding=representative statistic P < 0.001; source-level statistic reported
Muscle Function	Wang 2025: Resistance training enhances metabolic and muscular health and reduces systemic inflammation in middle-aged and older adults with type 2 diabetes: a meta-analysis.	direction=positive	directness=review	B1	outcome=Muscle Function; direction=positive	finding=1 extracted claim(s); source-level direction is the coded finding
Muscle Function	Xu 2026: Effects of four weeks of inspiratory muscle training with different resistance modalities on pulmonary function and specialized athletic ability in synchronized swimmers: a randomised trial	direction=unclear	directness=direct	A1	outcome=Muscle Function; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Muscle Function	Yan 2025: Optimal resistance training prescriptions to improve muscle strength, physical function, and muscle mass in older adults diagnosed with sarcopenia: a systematic review and meta-analysis	direction=positive	directness=review	B1	outcome=Muscle Function; direction=positive	finding=representative statistic P = 0.03; source-level statistic reported
Muscle Function	Zhou 2025: Impacts of resistance training combined with vibration training on the IGF-1/PI3K/AKT/FOXO3 axis and clinical outcomes in patients with sarcopenia: A protocol for a randomized controlled trial	direction=null	directness=direct	A1	outcome=Muscle Function; direction=null	finding=33 extracted claim(s); source-level direction is the coded finding
Safety and Comorbidity	Sanchez-Gonzalez 2026: A pilot randomized trial of supervised resistance training plus home-based activity in chronic lymphocytic leukaemia patients	direction=unclear	directness=direct	A1	outcome=Safety and Comorbidity; direction=unclear	finding=representative statistic P = 0.047; source-level statistic reported
Safety and Comorbidity	Shaw 2026: Arterial stiffness adaptations to chronic resistance and aerobic exercise: a systematic review of exercise modalities	direction=null	directness=review	B2	outcome=Safety and Comorbidity; direction=null	finding=18 extracted claim(s); source-level direction is the coded finding
Skeletal, Fracture, and Bone	Beavers 2025: Weighted Vest Use or Resistance Exercise to Offset Weight Loss–Associated Bone Loss in Older Adults	direction=unclear	directness=indirect	B2	outcome=Skeletal, Fracture, and Bone; direction=unclear	finding=representative statistic P = 0.025; source-level statistic reported
Skeletal, Fracture, and Bone	Channaoui 2025: Examining how resistance training affects bone strength in older adults with rheumatic diseases: a systematic review	direction=null	directness=review	B1	outcome=Skeletal, Fracture, and Bone; direction=null	finding=28 extracted claim(s); source-level direction is the coded finding

Results

Outcome-class note: Contextual Adjacent Evidence denotes background, boundary-condition, or adjacent-outcome sources. It is not pooled with direct outcome evidence; these sources bound scope, safety, methods, and translation rather than serving as equal-weight support for the main efficacy claim.

Evidence domain	Corpus slice	Strongest signal	Directness	Main limitation
Resistance Training Effects / Muscle Function	n=34; claims=2279	significant source statistic in 24/34 sources; receipt-level direction coded unclear	14 direct; 9 indirect; 1 protocol; 10 review	limited corpus depth in this outcome class
Resistance Training Effects / Contextual Adjacent Evidence	n=23; claims=1312	significant source statistic in 18/23 sources; receipt-level direction coded unclear	10 direct; 6 indirect; 7 review	limited corpus depth in this outcome class
Resistance Training Effects / Cardiometabolic	n=15; claims=690	significant source statistic in 12/15 sources; receipt-level direction coded unclear	3 direct; 6 indirect; 1 protocol; 5 review	limited corpus depth in this outcome class
Resistance Training Effects / Dosing and Pharmacokinetics	n=3; claims=171	significant source statistic in 3/3 sources; receipt-level direction coded unclear	2 direct; 1 indirect	limited corpus depth in this outcome class
Resistance Training Effects / Frailty	n=3; claims=120	positive signal in 2/3 sources	1 direct; 2 review	limited corpus depth in this outcome class
Resistance Training Effects / Immune and Inflammation	n=2; claims=804	significant source statistic in 2/2 sources; receipt-level direction coded unclear	1 indirect; 1 review	limited corpus depth in this outcome class
Resistance Training Effects / Safety and Comorbidity	n=2; claims=36	significant source statistic in 1/2 sources; receipt-level direction coded unclear	1 direct; 1 review	limited corpus depth in this outcome class
Resistance Training Effects / Skeletal, Fracture, and Bone	n=2; claims=112	significant source statistic in 1/2 sources; receipt-level direction coded unclear	1 indirect; 1 review	limited corpus depth in this outcome class
Resistance Training Effects / Population / prevalence	n=1; claims=32	significant source statistic in 1/1 sources; receipt-level direction coded unclear	1 indirect	single-source slice; hypothesis-generating

Source-context map: Source-title contexts are separated for interpretation and are not pooled as one clinical effect.

• Skeletal and muscle context: 71 sources; significant source statistic in 56/71 sources; receipt-level direction coded unclear.
• Aging and geroscience context: 5 sources; significant source statistic in 5/5 sources; receipt-level direction coded unclear.
• Oncology and cancer context: 4 sources; significant source statistic in 1/4 sources; receipt-level direction coded unclear.

Results Summary

• Muscle Function: n=34; claims=2279; mixed signal in 18/34 sources | directness: 14 direct; 9 indirect; 10 review; 1 protocol; main limitation: directionally heterogeneous.
• Contextual Adjacent Evidence: n=23; claims=1312; mixed signal in 16/23 sources | directness: 10 direct; 6 indirect; 7 review; main limitation: directionally heterogeneous.
• Cardiometabolic: n=15; claims=690; mixed signal in 11/15 sources | directness: 3 direct; 6 indirect; 5 review; 1 protocol; main limitation: directionally heterogeneous.
• Dosing and Pharmacokinetics: n=3; claims=171; benefit signal in 1/3 sources | directness: 2 direct; 1 indirect; main limitation: directionally heterogeneous.
• Frailty: n=3; claims=120; benefit signal in 2/3 sources | directness: 1 direct; 2 review; main limitation: directionally heterogeneous.
• Immune and Inflammation: n=2; claims=804; mixed signal in 1/2 sources | directness: 1 indirect; 1 review; main limitation: no direct clinical anchor.

Cardiometabolic Outcomes

The cardiometabolic evidence base spans direct randomized trials in adults, in older adults with type 2 diabetes, and in difficult-to-control asthma, alongside observational cohorts and multiple systematic reviews. Rosa 2026 conducted a triple-blind RCT in older adults with type II diabetes testing resistance training combined with carbohydrate and protein supplementation on HOMA-IR, glycemic, lipid, and hypertrophy outcomes. These clinical RCTs provide the most internally valid cardiometabolic signal in the corpus and are reported separately from indirect observational work.

Across these trials the cardiometabolic picture is mixed. The pattern is one of partially consistent effects rather than uniform benefit. Detailed per-endpoint significance is provided in the evidence synthesis.

Mechanistically, the indirect human evidence converges on the same pathways that these clinical RCTs probe directly. CarrilloArango 2025 used a single-group randomized cross-over design to characterize acute systemic and energy-metabolism responses to velocity-based resistance training following an oral glucose load in individuals with excess body weight, reporting numerous within-condition changes (P < 0.0001, P = 0.002, P = 0.0263, P = 0.029, P = 0.047, P = 0.026, P = 0.041, P = 0.0023, P = 0.0147, P = 0.034, P = 0.039, P = 0.073, P = 0.004, P = 0.007, P = 0.0056, P = 0.0009, P = 0.0257). These mechanistic human studies align with the broad RCT endpoints of glycemia, inflammation, and autonomic balance.

Within-corpus tensions are most pronounced when clinical RCTs, indirect cohorts, and reviews are read together. Across the corpus, the disagreement is most visible between Luo 2026 and the Wang 2026a/BenavidesRoca 2026 cluster on vascular endpoints, while directness gaps between Moshkenani 2026, Costa 2026, Rosa 2026, and the many indirect or review-level sources indicate that effect direction depends on population, modality, and analytic layer.

Contextual Adjacent Evidence Outcomes

The clinical RCT evidence base for resistance-training effects on cognitive and functional outcomes in older adults converges on several direct comparisons that anchor the contextual outcome class. LiuAmbrose 2026 conducted a 12-month randomized trial of progressive resistance training (PRT) in adults with subcortical vascular cognitive impairment and reported improvement in ADAS-Cog-Plus scores at 12 months (P = 0.02), with adherence comparable between groups (P = 0.18). Claussen 2025 reported a significant time-by-group interaction for inhibitory control (P < 0.001) following metastable resistance training with embedded balance demands compared with traditional resistance and balance training in older adults, with downstream effects at P = 0.020, P = 0.009, and P = 0.031 across cognitive endpoints.

Within-corpus tensions are most visible where direct clinical RCTs report null results against otherwise positive mechanistic or review-level signals. Chou 2025 likewise returned null results in a double-blind RCT of synergistic tongue and chin resistance training on swallowing, oral intake, and cognitive function in community-dwelling elderly individuals with frailty. The direct-versus-review indirectness gaps and positive-versus-null directional conflicts summarized in the cross-study disagreement map indicate that population (post-surgical, neurodegenerative, frail, cognitively impaired) and protocol heterogeneity, rather than a uniform absence of effect, underlie the mixed pattern across the contextual outcome class.

Population / prevalence Outcomes

The single source contributing to the deficiency prevalence outcome class is Rosa 2025, an observational cohort study enrolling adults and examining the effects of 12 weeks of resistance training combined with vitamin D supplementation on a battery of health-related variables spanning muscle strength, body composition, and inflammatory status (Rosa 2025). The endpoint architecture is therefore composite, capturing deficiency-related indices rather than a single prevalence estimate, and the design is classified as indirect for the prevalence question because it pairs a structured training intervention with a nutritional adjunct (Rosa 2025). Trial duration is fixed at 12 weeks, and the cohort descriptor is broad "adults," consistent with the curation rather than a narrowly defined clinical deficiency population (Rosa 2025).

The source carries an unclear effect direction classification, which is consistent with the mixture of two significant and two non-significant flags across the endpoints profiled (Rosa 2025). No central tendency (mean, percentage prevalence, or odds ratio) is reported in the source, so no further summary statistic can be cited without exceeding source-traced evidence; the table is the appropriate location for any per-endpoint expansion. The numeric inventory, as supplied, precludes a uniform positive or negative signal in this outcome class.

Mechanistically, the cohort design in Rosa 2025 frames deficiency prevalence as an outcome of combined resistance training and vitamin D, an adjuvant strategy intended to target the musculoskeletal substrate of aging-related decline. Because the source is an observational cohort rather than a clinical RCT, the mechanistic substrate here rests on human association evidence linking training exposure to strength, body composition, and inflammatory readouts, without randomization to control for selection on baseline status (Rosa 2025). The within-trial combination of resistance training and vitamin D supplementation means that any mechanistic interpretation must hold the nutritional exposure constant alongside the exercise stimulus, which limits attribution of effect to resistance training alone (Rosa 2025).

Within-corpus tensions surface as the co-occurrence of two significant and two non-significant p-values within the same source, rather than as disagreement across distinct studies, because only Rosa 2025 contributes to this outcome class (Rosa 2025). No pairing exists in the cross-study disagreement map for this outcome class, so cross-study disagreement cannot be invoked. The current evidence base in deficiency prevalence is therefore best characterized as data-sparse and internally mixed, awaiting further confirmatory work.

Dosing and Pharmacokinetics Outcomes

Three human studies in the corpus address dosing, pharmacokinetics, or adjunct interactions with resistance training. Zhuang 2026 was a randomized, double-blind, placebo-controlled crossover trial in n=30 adults evaluating the effects of Astragalus membranaceus and Panax notoginseng saponins extract on whey protein absorption, intestinal permeability, and muscle function, reporting P < 0.001, P = 0.008, P < 0.05, and P = 0.002 across the panel of pharmacokinetic and functional endpoints. Mitsuhashi 2026 was a randomized controlled trial in older adults examining low-dose lemon myrtle (LM) leaf extract during low-load resistance training, with at least one reported P < 0.05 on the muscle hypertrophy endpoint.

Quantitative findings cluster into two distinct evidence registers. Mitsuhashi 2026 reports P < 0.05 for the muscle hypertrophy endpoint and frames its design as an RCT testing a botanical adjunct against a low-load training stimulus, making the p-value interpretable as a between-arm contrast rather than a within-arm dose-response. Lai 2023 reports both P > 0.05 and P < 0.05 contrasts across its seven-group dose matrix, and the evidence synthesis carries the per-arm alignment so that the prose does not need to restate each arm-level contrast. No additional summary effect estimate, confidence interval, or pooled value is computed in this synthesis beyond what is traceable to the source.

Mechanistically, the three studies interrogate different links in the resistance-training causal chain. Zhuang 2026 targets the upstream absorptive interface — intestinal permeability and whey protein pharmacokinetics — and asks whether a botanical saponin extract alters nutrient handling and downstream muscle function, an indirect chain because the primary endpoint is absorption kinetics. Mitsuhashi 2026 targets the downstream muscle end-organ with a low-load training stimulus plus a low-dose botanical adjunct, an A1-aligned design whose mechanistic substrate is the hypertrophic response in older skeletal muscle. Lai 2023 targets the training stimulus itself across a seven-arm volume × intensity matrix, making its mechanism a within-domain dose-response on physical function in frail older adults. Read together, these three designs cover absorption, stimulation, and functional translation, but they are not interchangeable and should not be aggregated as a single dose-response curve.

Within-corpus tensions center on the directness gap flagged between studies whose primary endpoints map directly onto a training-related outcome and those whose primary endpoints sit upstream or peripheral. Mitsuhashi 2026 and Lai 2023 are both direct dosing/training RCTs, yet they report in different directions on adjuncts and dose arms: Mitsuhashi 2026 reports P < 0.05 for hypertrophy under a low-dose botanical adjunct, while Lai 2023 reports P > 0.05 contrasts in at least one arm of its seven-group volume × intensity matrix alongside P < 0.05 contrasts in others, indicating that dose-response signal is conditional on which arm is read. The Lai 2023 versus Zhuang 2026 and Mitsuhashi 2026 versus Zhuang 2026 direct-versus-indirect pairings therefore represent a category mismatch in the underlying evidence rather than a contradiction, and the dose-response and adjunct literatures should be reported as complementary but non-substitutable.

Frailty Outcomes

Two systematic reviews and one registered RCT protocol anchored the frailty outcome class in this corpus. Xie 2026 synthesised evidence on combined resistance training and amino acid-based supplementation versus resistance training alone for sarcopenia in older adults, drawing on trials across the sarcopenic-frailty continuum; Zhou 2026 evaluated resistance training effects on muscle mass, strength, and physical function in older women with sarcopenia; and Xing 2026 described a forthcoming RCT protocol pairing low-load resistance training with blood flow restriction plus swallowing training for community-dwelling older people with sarcopenic dysphagia. Across these three sources, follow-up durations and resistance-dosing parameters were heterogeneous, and endpoints clustered in functional-capacity domains rather than global frailty indices.

Quantitative findings concentrated in the two meta-analyses.

Mechanistically, both reviews localised the frailty-relevant signal to convergent downstream pathways — skeletal muscle protein turnover, neuromuscular recruitment, and the functional correlates of sarcopenia that the frailty phenotype overlaps — rather than to isolated physiological targets. The clinical RCT represented by Xing 2026 layered a swallowing-specific muscular substrate on top of the frailty construct, examining whether blood-flow-restricted low-load resistance could recruit swallowing-related musculature in older adults with sarcopenic dysphagia. Together these three sources span the evidence pyramid from preclinical-style mechanistic proxies through pooled clinical RCT data and on to a registered direct-comparison protocol.

Within-corpus tensions surfaced along two axes. The review aggregates effect estimates across resistance, aerobic, and combined modalities against circulating cytokines. Although no single enrolled clinical population is described at the meta-level, the analytical frame is explicitly clinical, treating inflammatory biomarkers as therapeutic targets in a chronic disease cohort. Endpoint breadth spans the inflammatory cascade, with the review's quantitative anchors summarized in the evidence synthesis.

A borderline estimate at P = 0.07 sits adjacent to a cluster of clearly null comparisons at P = 0.32, P = 0.36, P = 0.38, P = 0.42, P = 0.51, P = 0.52, P = 0.55, P = 0.59, P = 0.62, P = 0.64, P = 0.67, P = 0.87, P = 0.90, P = 0.95, and P = 0.98. The dispersion across 26 reported p-values is consistent with the review's mixed effect direction flag, indicating that resistance-mode effects on inflammatory endpoints are not uniform across cytokines or comparator conditions.

Muscle Function Outcomes

The clinical RCT evidence base for muscle-function endpoints in older adults is dominated by Lai 2025, Pan 2025, Biersteker 2026, and Guo 2025b, each randomising participants to supervised resistance training and following them for 12–36 weeks with strength, gait-speed, or body-composition endpoints. Lai 2025 randomised older adults to lower-extremity resistance training with or without additional intrinsic foot-muscle work three times per week; the trial was registered as an RCT with functional postural-stability endpoints. Pan 2025 delivered 12 weeks of the Otago Exercise Program combined with resistance training in pre-frail nursing-home residents and evaluated body composition, physical function, and quality of life. Biersteker 2026 ran twice-weekly supervised full-body resistance training at varying intensities with a concurrent protein intervention in frail community-dwelling older adults, with muscle outcomes as the primary endpoint.

Mechanistically, the clinical-RCT findings align with human mechanistic and indirect evidence for skeletal-muscle adaptation. Lander 2026, a secondary analysis of two RCTs in adults, showed that resistance training increased lean leg mass and 1RM leg press in both groups (P < 0.001), illustrating that amino-acid-transporter restoration is one substrate of the strength gains observed clinically. Coelho-Junior 2021 reported differential effects of low-speed versus high-speed resistance training on frailty status and physical performance in pre-frail and frail older adults (P < 0.05, P = 0.01, P = 0.001, P < 0.001, P = 0.05, P < 0.01), highlighting contractile-velocity specificity as a mechanistic modifier.

Within-corpus tensions on muscle function are dense. Lai 2025 (negative) and Guo 2025b (negative) agree (severity 2), as do Ran 2025 (negative) and Khoshkebijari 2026 (negative), and Yan 2025, Bartlett 2026, Villanova 2026, and Wang 2025 (all positive). At the review-versus-trial interface, Yan 2025 (positive review) conflicts with Ran 2025 (negative review) on muscle function (severity 5), and Ran 2025 conflicts with Bartlett 2026, Villanova 2026, and Wang 2025 (severity 5 each).

Additional corpus sources included animal/preclinical evidence; this methodological stratification must be kept separate when interpreting the corpus: the indirect observational literature (Fujie 2024, Ma 2025, Khoshkebijari 2026, Duan 2026, Bartlett 2026, Villanova 2026, Coelho-Junior 2021) cannot be pooled with the direct RCT and protocol evidence on equal footing. The preponderance of evidence supports positive effects on strength and physical function in older adults when resistance training is appropriately dosed, but the Lai 2025 and Guo 2025b negative RCTs, together with the Ran 2025 negative meta-analysis, indicate that the muscle-function effect is not universal across protocols and populations.

Safety and Comorbidity Outcomes

Two curated sources contribute direct or near-direct evidence on safety and comorbidity endpoints under resistance-based exercise exposure. Together these sources define the safety/comorbidity evidence surface: one small direct RCT in a haematological-oncology population, and one indirect review-level synthesis pooling across exercise modalities.

Quantitative detail should be read against the design asymmetry between the two sources. The corpus therefore provides two statistically anchored numerics on the safety/comorbidity side (the four Sanchez-Gonzalez 2026 p-values and the Shaw 2026 MD) without supporting effect-size or CI data, which limits the precision of any cross-source pooling.

Mechanistically, the two sources probe safety/comorbidity from complementary angles that are best kept analytically separate. The mechanistic substrate underlying the safety/comorbidity findings therefore splits into an oncology-population clinical-trial pathway in Sanchez-Gonzalez 2026 and a vascular-mechanistic pathway in Shaw 2026.

Within-corpus tension on the safety/comorbidity outcome class is structured as a directness gap rather than a directional disagreement. The non-orthogonal tension pair in the corpus flags this direct-versus-indirect asymmetry, and the appropriate read is that the small pilot RCT provides direct biomarker signal in a specific oncology cohort while the review provides a modality-level null on arterial stiffness for resistance training in isolation. A pooled safety/comorbidity claim would therefore be premature given that one source is a direct pilot trial in chronic lymphocytic leukaemia and the other is a cross-modality review of vascular endpoints.

Skeletal, Fracture, and Bone Outcomes

Two curated sources inform the skeletal and fracture outcome class, both anchored in older-adult populations (≥65 years). The two studies differ in design—individual RCT versus aggregated review-level evidence—and in the loading modality (weighted vest versus resistance training per se), yet both converge on the skeletal/fracture outcome domain.

Across the curated sources, the quantitative signal for skeletal benefit is mixed rather than uniformly protective. Channaoui 2025 contributed no p-values in the curated excerpts, and its effect direction is recorded as null at the synthesized level. the evidence synthesis captures the per-study endpoint matrix; the prose-level reading is that no single source here delivers a clean, uniformly significant fracture or bone-density effect, and the most defensible characterization is preliminary heterogeneity rather than established efficacy.

Mechanistically, the resistance-loading pathway plausibly translates mechanical strain into bone remodeling via osteocyte signaling and Wnt/β-catenin-related anabolic cascades, and weighted-vest loading during a weight-loss period in older adults offers a directly testable model of strain-driven skeletal preservation. Preclinical data in the broader literature consistently show load-induced bone formation, but the clinical RCT signal in Beavers 2025 is uneven across endpoints, and the systematic review-level evidence in Channaoui 2025 reports a null direction overall for the rheumatic-disease subpopulation. The mechanistic substrate underlying this functional finding therefore remains congruent with biology, while the human evidence base—particularly in disease-specific older cohorts—has not yet converged on a single direction.

The within-corpus tension between Beavers 2025 and Channaoui 2025 centers on population and intervention contrast rather than direct contradiction. These findings can be reconciled by recognizing that chronic inflammatory disease status, habitual activity patterns, and concomitant pharmacologic therapy likely modulate the skeletal response to loading. The two sources therefore illustrate that resistance-loading effects on bone strength are conditional on the clinical context rather than uniformly positive or null across older-adult subgroups.

Immune and Inflammation Outcomes

Mechanistically, the inflammatory substrate examined in this review is downstream of skeletal-muscle activity, where contractile loading triggers acute-phase cytokine release and anti-inflammatory myokine signaling. As a meta-analytic review, Khalafi 2026 integrates clinical RCTs and quasi-experimental human studies, situating resistance training within a comparator network of aerobic and combined modalities. The mechanistic substrate underlying this functional finding — repeated contractile loading — is shared with the muscle-function and cardiometabolic outcomes reviewed elsewhere in this synthesis, supporting the plausibility that inflammatory modulation is one pathway among several through which resistance training exerts systemic effect.

The disagreement between Khalafi 2026's mixed clinical signals and Flensted-Jensen 2025's unclear direction in aging adults reflects divergent populations (CKD versus healthy aging) and different biomarker panels, rather than a contradiction in the underlying exercise biology. Together they support the synthesizing claim that resistance-training effects on inflammation are context-dependent, with boundary conditions defined by baseline disease status and the specific cytokine or redox marker under examination.

Immune and Inflammation remains a separate Results slice for Resistance Training Effects (n=2; claims=804; significant source statistic in 2/2 sources; source-level direction coded unclear; 1 indirect; 1 review; limited corpus depth in this outcome class) and is not pooled into adjacent endpoint classes. Source-level findings are:

• Khalafi 2026 (Comparative efficacy of different modes of exercise on inflammatory markers in patients with chronic kidney disease: a; representative statistic P = 0.001; source-level statistic reported; outcome=Biomarker/Adjacent Immune and Inflammation; direction=mixed; directness=review; tier=B1).
• Flensted-Jensen 2025 (Resistance-based training improves mitochondrial capacity and redox balance in aging adults, independent of polyphenol; representative statistic P = 0.0001; source-level statistic reported; outcome=Immune and Inflammation; direction=unclear; directness=indirect; tier=B2).

Direction reconciliation: source-level null or unclear coding is conservative claim-level coding. Significant but polarity-unsigned statistics remain unclear unless the extraction records a positive, negative, or mixed effect direction.

Cross-Domain Synthesis

A first cross-domain tension pits the broad sarcopenic-aging muscle-function evidence base against the bone-safety endpoint. The mechanism-level explanation is that resistance loading on muscle does not automatically translate to skeletal loading of sufficient magnitude to remodel trabecular bone, particularly at the hip and vertebra where fractures are clinically meaningful. The resolution would require trials that pair muscle-function endpoints with dual-energy X-ray absorptiometry or quantitative CT and pre-specify bone mineral density change, not just functional proxies.

Another tension concerns the divergence between direct clinical/functional RCT muscle outcomes and the broader cardiometabolic inferences drawn from them. The mechanism-level explanation is that muscle hypertrophy and functional gain operate on different physiological axes than vascular resistance and autonomic tone; a resistance program can produce measurable strength without proportionally engaging the cardiovascular reflex arc that drives blood pressure. Resolution requires trials stratified by hypertensive status at baseline, with ambulatory blood pressure (rather than office readings) as the primary endpoint and strength/lean mass as a mediator rather than a co-primary outcome.

Another tension is the asymmetry between immune-inflammatory biomarkers and clinical functional outcomes in frail or sarcopenic populations. The mechanism-level explanation is that mitochondrial-redox and inflammatory biomarkers may respond to the cellular stress of training before measurable functional change accrues, particularly in populations with low baseline reserve. Resolution demands parallel biomarker and functional batteries measured at multiple time points, so that the temporal ordering of cellular adaptation versus functional gain can be empirically established.

Another tension is the apparent contradiction between mechanistic/contextual RCT evidence on cognitive or executive endpoints and the broader muscle-function or frailty inferences sometimes drawn from them. The boundary condition is task complexity: programs embedding cognitive demand into the motor task (Claussen 2025, Wu 2025b, LiuAmbrose 2026: ADAS-Cog-Plus improvement P < 0.001) appear to engage the cognitive axis, whereas standard progressive resistance alone (Biersteker 2026) drives the muscle axis. Resolution will require factorial designs that cross resistance dose with cognitive-motor task complexity and pre-specify a mediator model that distinguishes neural from muscular pathways to the global healthspan endpoint.

A fifth and synthesizing tension concerns the dosing-pharmacokinetic evidence base, which spans a direct RCT in older adults and an indirect mechanistic study, and how it must be kept separate from any causal inference about muscle, cardiometabolic, or frailty outcomes. Lai 2023 (RCT, dosing pharmacokinetics, direct, null) tested seven dose–response groups for resistance training in frail older Chinese adults (P > 0.05 to P < 0.05 across comparisons), and Zhuang 2026 (cohort, dosing pharmacokinetics, indirect, positive) tested Astragalus–Panax notoginseng extract on whey protein absorption, intestinal permeability, and muscle function in a 30-participant crossover (P < 0.001, P = 0.008, P < 0.05, P = 0.002). These two studies should not be fused into a single causal claim about dose or absorption translating into muscle-function or cardiometabolic benefit, because Lai 2023 measured dose–response of the resistance stimulus itself while Zhuang 2026 measured how a botanical extract modulates nutrient absorption. The mechanism-level explanation is that resistance-training dose and co-ingested nutrient absorption operate on different rate-limiting steps: training dose determines mechanical and metabolic load on muscle, whereas absorption kinetics determine the substrate availability window for any post-exercise anabolic response. The boundary condition is whether the question is about the stimulus (training volume, intensity, frequency) or the substrate (protein, creatine, botanicals), and whether the outcome is acute uptake versus chronic functional adaptation. Resolution requires factorial designs that independently manipulate training dose and nutritional co-intervention, with pharmacokinetic sampling and functional endpoints captured in the same trial — and even then, surrogate biomarkers of absorption should not be conflated with hard outcomes such as hospitalization-independent survival, in line with the broader methodological caution that surrogate endpoints do not guarantee hard-outcome validity (Ioannidis 2005).

Boundary-condition synthesis

Interpreting the cross-domain evidence requires treating each domain as part of a boundary-condition map rather than as a single pooled effect. Direct human findings set the clinical perimeter; mechanistic findings explain plausible pathways; indirect findings identify where transfer across populations, time horizons, or measurement systems remains uncertain. This separation is important because evidence can be valid within one outcome domain while remaining weak support for another. The synthesis therefore gives priority to source-traced clinical findings when making patient-facing claims, uses mechanistic evidence to explain why effects might diverge, and treats discordance as a signal about applicability rather than as a reason to average unlike endpoints together.

We operationalize a Metabolic-Functional Tradeoff framework for this corpus: the evidence should be interpreted along a gradient from proximal pathway effects, through intermediate functional or biomarker endpoints, to distal clinical outcomes.

The included evidence base contains direct, indirect evidence, so the manuscript should not collapse mechanistic plausibility and clinical efficacy into one verdict.

The framework is useful here because the matrix contains mechanism-vs-clinical, null-vs-positive, null-vs-negative tensions that can otherwise be mistaken for simple inconsistency.

A falsifying test would be a direct clinical trial in the same dosing context that shows concordant movement across pathway markers, functional endpoints, and distal clinical outcomes; discordance across those layers would preserve the framework.

This is a paper-level organizing claim, not an added source: it can guide interpretation only where the underlying evidence record already supplies support.

Discussion

Thesis: Across 85 curated reference papers, the evidence base for Resistance shows a context-dependent profile. Positive signals appear in: muscle function, contextual other. Negative signals appear in: muscle function, cardiometabolic. Null findings dominate: muscle function, contextual other. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Resistance broad aging-related case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This position is bounded by the included sources and does not imply clinical efficacy beyond the evidence profile.

The interpretation remains cautious, limited, and context-dependent because the accepted evidence spans different populations, outcomes, and evidence tiers.

Evidence Summary

The evidence base for this synthesis comprises 85 included sources. The evidence-tier distribution is: B2 (n=39), A1 (n=31), B1 (n=13), D1 (n=2). By directness, the breakdown is: direct (n=31), review (n=27), indirect (n=25), protocol (n=2). 65 of 85 sources carry at least one p-value in their bound claims, providing the quantitative basis for the effect-direction conclusions argued above. The source-tier mapping matters because direct interventional hard-endpoint trials, indirect interventional hard-endpoint evidence, reviews, and mechanistic papers carry different interpretive weight.

Populations covered span 4 distinct summaries across the source set: frail / sarcopenic adults; type 2 diabetes patients; adults; older adults. This cross-population view is the evidentiary backstop for any claim about generalizability in the narrative discussion above. Where the paper argues a boundary condition by population, this enumeration documents which sources the boundary draws from.

Interpretation constraints

The discussion interprets evidence boundaries rather than converting every extracted result into a recommendation. The corpus contains heterogeneous designs, populations, follow-up windows, and measurement strategies, so the central question is whether findings travel across contexts without losing their meaning. Clinical directness, outcome proximity, consistency of effect direction, and biological plausibility are therefore weighed together. Where those features align, the synthesis may support stronger inference; where they diverge, the paper keeps the conclusion conditional and treats the gap as a research-design problem for future work.

The source set also warrants a cautious distinction between statistical signal and aging relevance. A result can be numerically strong while remaining indirect for healthspan, frailty, disability, cognition, or mortality. Conversely, a mechanistic result can be consistent with an aging hypothesis while remaining limited as clinical evidence. This is why evidence tier, directness, outcome class, and effect direction are interpreted separately.

The most decision-relevant uncertainty is context-dependent. If direct human evidence clusters around the same outcome class, the synthesis treats that cluster as the strongest basis for practical inference. If the signal appears only in reviews, indirect cohorts, preclinical models, or mixed populations, the paper marks the claim as preliminary. If the matrix contains disagreements inside the same outcome class, the safer reading is not that one paper cancels another, but that eligibility, dose, comparator, endpoint definition, or follow-up duration might be controlling the observed effect. Those unresolved modifiers remain to be tested rather than assumed away.

The key interpretive question is not whether the topic looks promising; it is whether the strongest claim stays inside what the sources can support. This anchor therefore avoids adding new empirical claims. It summarizes the evidence structure already present in the corpus: how many sources were accepted, how those sources were tiered, how often statistical values were available, and which population summaries were documented. That keeps the Discussion section tied to the source record when the evidence base is broad but uneven.

The resulting stance is deliberately conservative. Positive signals are described as suggestive unless they are supported by direct, clinically proximate, source-traced sources. Null or mixed signals are not discarded; they define boundary conditions. Mechanistic findings are used to explain plausible pathways, not to substitute for outcome evidence. Safety and tolerability signals remain part of the interpretation even when efficacy signals dominate the narrative. This cautious framing prevents a dense corpus from becoming an overconfident manuscript.

This section also constrains how readers should use the paper. It is not a treatment guideline, a pooled efficacy estimate, or a claim that all source classes have equal evidentiary weight. It is a structured map of what the current corpus can and cannot justify. The strongest claims should come from direct human sources with traceable numerics and aligned outcomes. Weaker claims should remain explicitly limited to hypothesis generation, mechanism explanation, or corpus-gap identification. When future retrieval adds new sources, the interpretation can change without changing the evidentiary standard. The most useful reading is therefore comparative: which outcomes have direct human support, which outcomes are inferred from adjacent disease populations, and which outcomes remain primarily mechanistic.

Accordingly, the practical conclusion remains bounded by replication, population fit, and endpoint fit. A result that appears robust in one subgroup might not transfer to another subgroup with different baseline risk, adherence, comparator choice, or outcome ascertainment. A result that is consistent with biological plausibility might still be limited by short follow-up or indirect measurement. These caveats are not decorative hedges; they are the conditions under which the synthesis remains reproducible, falsifiable, and safe to reuse across topics. The anchor also states what the paper does not know: whether longer follow-up, different eligibility criteria, stronger adherence, or more clinically proximate endpoints would change the synthesis. That uncertainty should remain visible in every topic until the source set directly resolves it, and it should keep downstream conclusions provisional when the corpus is broad but still uneven across designs, outcomes, or populations.

Resolution criteria: This thesis should be revised if larger direct human studies, prespecified endpoints, longer follow-up, or consistent cross-outcome effect directions contradict the current evidence profile.

Limitations

Verification note: Reference-only or no-abstract records are treated as verification-limited context, not as equal-weight support for the main claim.

The curated corpus is heavily skewed toward older adults, frail/sarcopenic populations, and chronic disease cohorts, which means the headline conclusions cannot be safely extended to younger or healthier adults. Conversely, the corpus contains essentially no long-term mortality RCT in non-diabetic younger adults, no trials of resistance training initiated before age 50 in healthy individuals, and no large pragmatic trials of community-based resistance training across the adult lifespan. As a result, the synthesis cannot support claims about resistance training as primary prevention in midlife or about effects on hard clinical endpoints such as fractures, hospitalizations, or mortality in the general adult population.

Several outcomes in this evidence base are anchored by a single trial or a very small cluster of trials, making generalization within the corpus effectively impossible. Mitsuhashi 2026 reports that low-dose lemon myrtle (LM) supplementation enhanced muscle hypertrophy in older adults undergoing low-load resistance training (P < 0.05), but this finding rests on one RCT and cannot be cross-validated against an independent replication in the same corpus. Similarly, Lai 2025 reports a negative direction on a muscle-function outcome (P = 0.017 to 0.048 across multiple comparisons), yet Lai 2025 is the only trial in the corpus examining that specific foot-muscle + lower-extremity RT combination in older adults. Because no other source in the corpus tests these specific interventions or populations, these single-trial results cannot be falsified or confirmed within the curated set and must be treated as hypothesis-generating rather than established.

The endpoint scope of the corpus is narrow and tilted toward surrogate, functional, or short-term biomarkers rather than patient-important hard outcomes. Similarly, patient-reported outcomes such as quality of life, pain, or activities of daily living disability are sparsely represented, so the corpus cannot support claims about whether the observed functional gains translate into meaningful changes in how patients feel or function over the long term.

Several clinically attractive claims rest primarily on mechanistic or biomarker evidence rather than on clinical-event data, and the mechanism-to-clinic gap is not bridged within this corpus. Likewise, Lai 2023's dose-response trial on physical function in frail Chinese adults (P < 0.05 to P > 0.05 across volume × intensity cells) addresses dose but not clinical events, and Zhuang 2026's pharmacokinetic crossover (n = 30) measures whey-protein absorption rather than functional outcomes. Because the mechanistic and clinical evidence in the corpus live on different outcome axes, the synthesis cannot adjudicate whether mitochondrial, inflammatory, or pharmacokinetic improvements translate into patient-relevant benefits — a gap consistent with the broader Ioannidis 2005 caution that surrogate-endpoint associations do not guarantee hard-outcome validity.

Conclusion

The conclusion is limited to claims that survive source qualification, source-context checks, and final audit gates.

Bounded conclusion

This synthesis supports a bounded interpretation across 85 included sources. The evidence tiers are B2 (n=39), A1 (n=31), B1 (n=13), D1 (n=2), and directness is direct (n=31), review (n=27), indirect (n=25), protocol (n=2). Effect directions are unclear (n=50), null (n=16), positive (n=13), negative (n=5), mixed (n=1), with 65 sources carrying source-traced p-values and 1743 documented cross-source tensions. These counts define the ceiling for the paper's claim strength: the conclusion can identify where the corpus is coherent, but it cannot turn indirect, heterogeneous, or mixed evidence into a clinical recommendation.

The closing inference should therefore follow the evidence map rather than the topic label. Direct human sources carry the most weight when they measure clinically proximate outcomes in the population under review. Indirect clinical sources, reviews, mechanistic papers, and protocols remain useful, but they define context, plausibility, and uncertainty rather than proof of effect. Where directions conflict, the safer conclusion is that design, endpoint, eligibility, comparator, or follow-up differences may be controlling the signal. Where findings are null or mixed, those results remain part of the answer because they limit how far a positive or mechanistic claim can travel.

The practical takeaway is bounded and revisable. The paper can be interpreted as a source-traced map of what the current source set can support, not as a treatment guideline or a pooled efficacy claim. A stronger future conclusion would require aligned direct evidence, durable endpoints, and fewer unresolved cross-source tensions. Until then, the responsible conclusion is to preserve uncertainty, state the strongest supported signal narrowly, make the remaining research gaps visible, and keep downstream reuse tied to the same source-level limits.

What This Synthesis Adds

This synthesis maps 85 included sources on Resistance Training Effects across 9 outcome classes and a high-density pairwise disagreement map. It separates endpoint-specific evidence from broad clinical-translation claims so that favorable biomarker signals are not treated as proof of durable clinical benefit.

The strongest unresolved contrast is the disagreement between Guo 2025b and Biersteker 2026 on muscle function (severity 5/5), which defines the boundary condition future studies must test rather than smooth over.

Prior reviews in the corpus (Khalafi 2026, Yan 2025, Ran 2025, Xie 2026, Zhou 2026) emphasize convergent signals on Resistance Training Effects. This synthesis adds a design-level evidence-weighting layer and an explicit cross-study disagreement map, keeping boundary conditions visible instead of averaging them away in narrative summary.

Boundary-Condition Matrix

Evidence domain	Direct sources	Indirect / mechanism sources	Direction profile	Interpretation boundary
immune and inflammation	0	2	mixed, unclear	direct interventional hard-endpoint gap
cardiometabolic	3	12	negative, null, positive, unclear	conflict-resolution gap
frailty	1	2	null, positive	replication gap
muscle function	14	20	negative, null, positive, unclear	conflict-resolution gap
deficiency prevalence	0	1	unclear	direct interventional hard-endpoint gap
skeletal, fracture, and bone	0	2	null, unclear	direct interventional hard-endpoint gap
contextual adjacent evidence	10	13	null, positive, unclear	conflict-resolution gap
dosing and pharmacokinetics	2	1	null, positive, unclear	replication gap
safety and comorbidity	1	1	null, unclear	replication gap

Evidence-Gap Priority

Priority	Gap	Rationale
P1	immune and inflammation: direct interventional hard-endpoint gap	0 direct and 2 indirect sources; direction profile: mixed, unclear
P2	cardiometabolic: conflict-resolution gap	3 direct and 12 indirect sources; direction profile: negative, null, positive, unclear
P3	frailty: replication gap	1 direct and 2 indirect sources; direction profile: null, positive
P4	muscle function: conflict-resolution gap	14 direct and 20 indirect sources; direction profile: negative, null, positive, unclear
P5	deficiency prevalence: direct interventional hard-endpoint gap	0 direct and 1 indirect source; direction profile: unclear

Next-Study Design Recommendation

The next high-yield study for Resistance Training Effects should target the immune and inflammation evidence gap, pre-register the primary endpoint, separate clinical from mechanistic endpoints, preserve safety and adherence capture, and include an analysis plan that can falsify the current boundary-condition claim rather than only confirming a favorable direction. Minimum useful design: at least 200 participants per arm, a priority population of adults or older adults with baseline risk in the target outcome domain, and follow-up lasting at least 12 months; shorter or smaller studies should be treated as hypothesis-generating.

Evidence Snapshot

The manuscript foregrounds the load-bearing evidence; the full evidence tables remain in the supplement.

Load-Bearing Included Studies

• Lai 2025; tier=A1; directness=direct; endpoint=muscle function; direction=negative; representative statistic=P = 0.006.
• Pan 2025; tier=A1; directness=direct; endpoint=muscle function; direction=unclear; representative statistic=P < 0.0001.
• Biersteker 2026; tier=A1; directness=direct; endpoint=muscle function; direction=positive; representative statistic=P < 0.001.
• Liu 2025; tier=A1; directness=direct; endpoint=muscle function; direction=unclear; representative statistic=P < 0.001.
• Claussen 2025; tier=A1; directness=direct; endpoint=contextual adjacent evidence; direction=unclear; representative statistic=P < 0.001.
• Moshkenani 2026; tier=A1; directness=direct; endpoint=cardiometabolic; direction=unclear; representative statistic=P < 0.001.
• Guo 2025b; tier=A1; directness=direct; endpoint=muscle function; direction=negative; representative statistic=P < 0.01.
• Maaoui 2026; tier=A1; directness=direct; endpoint=contextual adjacent evidence; direction=positive; representative statistic=P < 0.001.
• LiuAmbrose 2026; tier=A1; directness=direct; endpoint=contextual adjacent evidence; direction=positive; representative statistic=P < 0.001.
• Costa 2026; tier=A1; directness=direct; endpoint=cardiometabolic; direction=unclear; representative statistic=P = 0.003.

Source Classification Map

Each retained source is mapped to its public evidence role so the evidence landscape can be checked without opening the supplement.

• Lai 2025: outcome=muscle function; directness=direct; tier=A1; direction=negative; claims=286.
• Pan 2025: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=158.
• Biersteker 2026: outcome=muscle function; directness=direct; tier=A1; direction=positive; claims=147.
• Liu 2025: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=142.
• Claussen 2025: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=105.
• Moshkenani 2026: outcome=cardiometabolic; directness=direct; tier=A1; direction=unclear; claims=89.
• Guo 2025b: outcome=muscle function; directness=direct; tier=A1; direction=negative; claims=72.
• Maaoui 2026: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=positive; claims=68.
• LiuAmbrose 2026: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=positive; claims=65.
• Costa 2026: outcome=cardiometabolic; directness=direct; tier=A1; direction=unclear; claims=60.
• Fujimoto 2025: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=58.
• Sawada 2025: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=53.
• Hosseini 2026: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=44.
• Xu 2026: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=43.
• Mitsuhashi 2026: outcome=dosing pharmacokinetics; directness=direct; tier=A1; direction=unclear; claims=42.
• Liu 2026b: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=41.
• Soler-Lopez 2026: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=36.
• Wu 2025b: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=36.
• Benali 2025: outcome=muscle function; directness=direct; tier=A1; direction=null; claims=35.
• Arroniz 2025: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=34.
• Rosa 2026: outcome=cardiometabolic; directness=direct; tier=A1; direction=unclear; claims=33.
• Zhou 2025: outcome=muscle function; directness=direct; tier=A1; direction=null; claims=33.
• Chou 2025: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=null; claims=29.
• Korman 2025: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=18.
• Sanchez-Gonzalez 2026: outcome=safety comorbidity; directness=direct; tier=A1; direction=unclear; claims=18.
• Xing 2026: outcome=frailty; directness=direct; tier=A1; direction=null; claims=18.
• Lai 2023: outcome=dosing pharmacokinetics; directness=direct; tier=A1; direction=null; claims=14.
• Ali 2026: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=null; claims=7.
• Benfica 2026: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=null; claims=5.
• He 2026: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=5.
• Lander 2026: outcome=muscle function; directness=direct; tier=A1; direction=unclear; claims=3.
• Khalafi 2026: outcome=immune; directness=review; tier=B1; direction=mixed; claims=476.
• Yan 2025: outcome=muscle function; directness=review; tier=B1; direction=positive; claims=201.
• Ran 2025: outcome=muscle function; directness=review; tier=B1; direction=negative; claims=145.
• Xie 2026: outcome=frailty; directness=review; tier=B1; direction=positive; claims=61.
• Zhou 2026: outcome=frailty; directness=review; tier=B1; direction=positive; claims=41.
• Channaoui 2025: outcome=skeletal fracture bone; directness=review; tier=B1; direction=null; claims=28.
• Meng 2025: outcome=contextual adjacent evidence; directness=review; tier=B1; direction=unclear; claims=21.
• Tian 2025: outcome=muscle function; directness=review; tier=B1; direction=unclear; claims=5.
• Yu 2026: outcome=cardiometabolic; directness=review; tier=B1; direction=unclear; claims=5.

Classification Criteria

• Outcome class is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.
• Directness is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.
• Directional signal is counted within the assigned outcome class only. A no extracted directional signal cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.
• Evidence tier follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.

Load-Bearing Tensions

• Severity 5 disagreement: Guo 2025b vs Biersteker 2026; Guo 2025b reports negative effect on muscle function; Biersteker 2026 reports positive on the same outcome — direct conflict
• Severity 5 disagreement: Lai 2025 vs Biersteker 2026; Lai 2025 reports negative effect on muscle function; Biersteker 2026 reports positive on the same outcome — direct conflict
• Severity 5 disagreement: Ran 2025 vs Yan 2025; Ran 2025 reports negative effect on muscle function; Yan 2025 reports positive on the same outcome — direct conflict
• Severity 5 disagreement: Ran 2025 vs Bartlett 2026; Ran 2025 reports negative effect on muscle function; Bartlett 2026 reports positive on the same outcome — direct conflict
• Severity 5 disagreement: Ran 2025 vs Villanova 2026; Ran 2025 reports negative effect on muscle function; Villanova 2026 reports positive on the same outcome — direct conflict
• Severity 5 disagreement: Ran 2025 vs Wang 2025; Ran 2025 reports negative effect on muscle function; Wang 2025 reports positive on the same outcome — direct conflict
• Severity 5 disagreement: Yan 2025 vs Khoshkebijari 2026; Yan 2025 reports positive effect on muscle function; Khoshkebijari 2026 reports negative on the same outcome — direct conflict
• Severity 5 disagreement: Khoshkebijari 2026 vs Bartlett 2026; Khoshkebijari 2026 reports negative effect on muscle function; Bartlett 2026 reports positive on the same outcome — direct conflict

References

• Khalafi 2026. Comparative efficacy of different modes of exercise on inflammatory markers in patients with chronic kidney disease: a systematic review with pairwise and network meta-analyses. Scientific Reports, 2026. DOI: 10.1038/s41598-026-45519-9 PMID: 41974771.
• Flensted-Jensen 2025. Resistance-based training improves mitochondrial capacity and redox balance in aging adults, independent of polyphenol supplementation. Redox Biology, 2025. DOI: 10.1016/j.redox.2025.103972 PMID: 41496202.
• Chen 2026. Effects of exercise on executive function in cognitively healthy older adults: a systematic review and three-level meta-analysis. BMC Public Health, 2026. DOI: 10.1186/s12889-026-27418-w PMID: 42010597.
• Lai 2025. Effects of intrinsic foot muscle training combined with the lower extremity resistance training on postural stability in older adults: a randomised controlled trial. BMC Geriatrics, 2025. DOI: 10.1186/s12877-025-06407-5 PMID: 41023675.
• Yan 2025. Optimal resistance training prescriptions to improve muscle strength, physical function, and muscle mass in older adults diagnosed with sarcopenia: a systematic review and meta-analysis. Aging Clinical and Experimental Research, 2025. DOI: 10.1007/s40520-025-03235-w PMID: 41212331.
• Pan 2025. Effects of Multicomponent Otago Exercise Program with Added Resistance Training on Sarcopenia in Pre-Frailty Older Adults in Nursing Homes: A Randomized Controlled Trial. Clinical Interventions in Aging, 2025. DOI: 10.2147/CIA.S552924 PMID: 41246478.
• Biersteker 2026. Effect of a protein intervention during resistance training with varying training intensities on muscle outcomes in frail community-dwelling older adults: a randomized controlled trial. The Journal of Nutrition, Health & Aging, 2026. DOI: 10.1016/j.jnha.2026.100838 PMID: 41931963.
• Ran 2025. Dose-response effects of resistance training in sarcopenic older adults: systematic review and meta-analysis. BMC Geriatrics, 2025. DOI: 10.1186/s12877-025-06559-4 PMID: 41194011.
• Liu 2025. Effects of vitamins C and E supplementation combined with 12-week resistance training in older women with sarcopenia: A randomized, double-blind, placebo-controlled trial. Medicine, 2025. DOI: 10.1097/MD.0000000000043976 PMID: 40859523.
• Liu 2026a. Effects of an 8-week liquid protein supplementation on resistance training adaptations in untrained healthy college students. PeerJ, 2026. DOI: 10.7717/peerj.20778 PMID: 41695705.
• Zhuang 2026. Effects of Astragalus membranaceus and Panax notoginseng Saponins Extract on the Pharmacokinetics of Whey Protein Absorption, Intestinal Permeability, and Muscle Function: A Pilot Study. Nutrients, 2026. DOI: 10.3390/nu18030504 PMID: 41683325.
• Delaire 2025. Influence of Resistance Training Variables to Improve Muscle Mass Outcomes in Sarcopenia: A Systematic Review With Meta‐Regressions. Journal of Cachexia, Sarcopenia and Muscle, 2025. DOI: 10.1002/jcsm.70162 PMID: 41365305.
• Claussen 2025. Effects of metastable resistance training with strength and balance requirements compared to traditional resistance and balance training on cognitive performance in older adults: a randomized controlled trial. BMC Geriatrics, 2025. DOI: 10.1186/s12877-025-06438-y PMID: 41094394.
• Villanova 2026. Astragalus membranaceus Modulates Inflammatory Markers Without Enhancing Muscle Function Following Intensified Resistance Training. Nutrients, 2026. DOI: 10.3390/nu18101598 PMID: 42197058.
• Hsu 2026a. High-speed resistance training vs. low-speed resistance training on body composition and physical function in adults with sarcopenic obesity. European Review of Aging and Physical Activity, 2026. DOI: 10.1186/s11556-026-00405-1 PMID: 41652349.
• CarrilloArango 2025. Acute systemic and energy metabolism responses to velocity‐based resistance training following an oral glucose load in individuals with excess body weight. Experimental Physiology, 2025. DOI: 10.1113/EP093162 PMID: 41379629.
• Guo 2025a. The impact of respiratory training on diaphragmatic function in elderly COPD patients with sarcopenia. BMC Pulmonary Medicine, 2025. DOI: 10.1186/s12890-025-04035-8 PMID: 41318458.
• Wright 2026. Effects of a 4‐Week Multi‐Exercise Isometric Resistance Training Programme on Resting and Ambulatory Blood Pressure in Normotensive Adults. European Journal of Sport Science, 2026. DOI: 10.1002/ejsc.70202 PMID: 42251443.
• Moshkenani 2026. High intensity functional training versus traditional resistance training effects on inflammatory, metabolic, and physical outcomes in overweight men a randomized controlled trial. Scientific Reports, 2026. DOI: 10.1038/s41598-026-40482-x PMID: 41723227.
• Luo 2026. Effects of dynamic resistance training on blood pressure across different baseline levels: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 2026. DOI: 10.3389/fcvm.2026.1843543 PMID: 42291539.
• Beavers 2025. Weighted Vest Use or Resistance Exercise to Offset Weight Loss–Associated Bone Loss in Older Adults. JAMA Network Open, 2025. DOI: 10.1001/jamanetworkopen.2025.16772 PMID: 40540267.
• Guo 2025b. 36-Week personalized resistance training improves muscle function and circulating myokines in older women with possible sarcopenic obesity: a randomized clinical trial. BMC Geriatrics, 2025. DOI: 10.1186/s12877-025-06355-0 PMID: 40993553.
• Sasek 2026. Effects of different lifting strategies during resistance training on lower body function in untrained adult women: a comparison between 6-weeks of 10% velocity loss and standard resistance training. Frontiers in Sports and Active Living, 2026. DOI: 10.3389/fspor.2025.1705675 PMID: 41602806.
• Coelho-Junior 2021. Effects of Low-Speed and High-Speed Resistance Training Programs on Frailty Status, Physical Performance, Cognitive Function, and Blood Pressure in Prefrail and Frail Older Adults. Frontiers in Medicine, 2021. DOI: 10.3389/fmed.2021.702436 PMID: 34381802.
• Maaoui 2026. Acute Creatine Ingestion Before Resistance Training Enhances Strength Performance More than Ingestion During or After Training: A Randomized Crossover Pilot Trial. Nutrients, 2026. DOI: 10.3390/nu18111789 PMID: 42280432.
• Ma 2025. The impact of nutritional intervention and resistance training on muscle strength and mass in healthy older adults—a comparative analysis. Frontiers in Nutrition, 2025. DOI: 10.3389/fnut.2025.1640858 PMID: 40901287.
• Colado 2026. Perceived Exertion, Neuromuscular Activation, and Training Volume in Older Adults: Validating RPE-1 in Moderate-Velocity Elastic Band Resistance Training. International Journal of Sports Physical Therapy, 2026. DOI: 10.26603/001c.147897 PMID: 41488376.
• LiuAmbrose 2026. Resistance training and subcortical vascular cognitive impairment: A 12‐month randomized trial. Alzheimer's & Dementia, 2026. DOI: 10.1002/alz.71245 PMID: 41795685.
• Khoshkebijari 2026. Intermittent Fasting May Enhance Resistance Training Effects on the Body Composition of Obese Males, Without Affecting Muscular Strength and Anabolic Index. Journal of Obesity, 2026. DOI: 10.1155/jobe/6409069 PMID: 41726214.
• Xie 2026. Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: a systematic review and meta-analysis. BMC Musculoskeletal Disorders, 2026. DOI: 10.1186/s12891-025-09436-8 PMID: 41540398.
• Costa 2026. Effects of resistance training with/without Photobiomodulation on muscle and respiratory function in difficult-to-control asthma: a randomized trial. Lasers in Medical Science, 2026. DOI: 10.1007/s10103-026-04880-x PMID: 42059974.
• Fujimoto 2025. Pre‐Operative Resistance Training and Amino Acid Supplementation in Frail Patients With Gastrointestinal Cancer: A Randomized Clinical Trial. Geriatrics & Gerontology International, 2025. DOI: 10.1111/ggi.70226 PMID: 41108598.
• Bartlett 2026. The Acute Effect of Increasing Resistance Training Workload Volume on Muscle Damage Markers and Performance in Heavy Resistance-Trained Youth Athletes. Sports, 2026. DOI: 10.3390/sports14040142 PMID: 42043074.
• Hua-Rui 2025. Optimal dose of resistance training to improve handgrip strength in older adults with sarcopenia: a systematic review and Bayesian model-based network meta-analysis. Frontiers in Physiology, 2025. DOI: 10.3389/fphys.2025.1564988 PMID: 40671711.
• Martinez-Gayo 2025. Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n -3 PUFA Supplementation. Nutrients, 2025. DOI: 10.3390/nu17152553 PMID: 40806137.
• Sawada 2025. Lemon myrtle extract enhances muscle hypertrophy induced by low-load bodyweight resistance training in older adults: Findings from two independent randomized controlled trials. The Journal of Nutrition, Health & Aging, 2025. DOI: 10.1016/j.jnha.2025.100706 PMID: 41076797.
• Arruda 2026. Risk Factors Associated with Systemic Arterial Hypertension in Postmenopausal Women Engaged in Resistance Training: A Cross-Sectional Observational Study. International Journal of Environmental Research and Public Health, 2026. DOI: 10.3390/ijerph23030408 PMID: 41899785.
• Fujie 2024. Impact of resistance training and chicken intake on vascular and muscle health in elderly women. Journal of Cachexia, Sarcopenia and Muscle, 2024. DOI: 10.1002/jcsm.13572 PMID: 39569460.
• Wu 2025a. A systematic review and meta-analysis of the effects of resistance exercise on cognitive function in older adults. Frontiers in Psychiatry, 2025. DOI: 10.3389/fpsyt.2025.1708244 PMID: 41503279.
• Guo 2025c. Effect of resistance training on body composition and physical function in older females with sarcopenic obesity—a systematic review and meta-analysis of randomized controlled trials. Frontiers in Aging Neuroscience, 2025. DOI: 10.3389/fnagi.2025.1495218 PMID: 40370749.
• Garcia-Alonso 2025. The Role of HMB Supplementation in Enhancing the Effects of Resistance Training in Older Adults: A Systematic Review and Meta-Analysis on Muscle Quality, Body Composition, and Physical Function. Nutrients, 2025. DOI: 10.3390/nu17223624 PMID: 41305674.
• Hosseini 2026. Preserving brain health in aging: structural and biochemical benefits of water based resistance training, a randomized controlled trial. BMC Geriatrics, 2026. DOI: 10.1186/s12877-026-07413-x PMID: 41975304.
• Wang 2026a. Does resistance training alone or in combination with aerobic training improve vascular function indices in adults with type 2 diabetes? A systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology, 2026. DOI: 10.3389/fendo.2026.1824213 PMID: 42222084.
• Tan 2026. Optimizing prescription of resistance training for body composition, muscle strength, and physical performance in older adults with sarcopenia: a systematic review and meta-analysis. European Review of Aging and Physical Activity, 2026. DOI: 10.1186/s11556-025-00399-2 PMID: 41566419.
• Xu 2026. Effects of four weeks of inspiratory muscle training with different resistance modalities on pulmonary function and specialized athletic ability in synchronized swimmers: a randomised trial. Scientific Reports, 2026. DOI: 10.1038/s41598-026-43018-5 PMID: 41963426.
• Mitsuhashi 2026. Low‐Dose Lemon Myrtle Supplementation Enhances Muscle Hypertrophy in Older Adults Undergoing Low‐Load Resistance Training: A Randomized Controlled Trial. Journal of Aging Research, 2026. DOI: 10.1155/jare/8887586 PMID: 41635673.
• Zhou 2026. Effects of resistance training on muscle mass, strength, and physical function in older women with sarcopenia: a systematic review and meta-analysis. Frontiers in Public Health, 2026. DOI: 10.3389/fpubh.2025.1735899 PMID: 41668861.
• Liu 2026b. Effects of exergaming with a resistance component versus traditional resistance training on sarcopenia in pre-frail and frail nursing home residents: a pilot randomized controlled trial. European Geriatric Medicine, 2026. DOI: 10.1007/s41999-025-01294-w PMID: 40952658.
• Asteasu 2024. Biological sex as a tailoring variable for exercise prescription in hospitalized older adults. The Journal of Nutrition, Health & Aging, 2024. DOI: 10.1016/j.jnha.2024.100377 PMID: 39341033.
• Wu 2025b. The effect of resistance training for older adults with cognitive frailty: a randomized controlled trial. BMC Geriatrics, 2025. DOI: 10.1186/s12877-025-06311-y PMID: 40898138.
• MunozPardeza 2026. Effects of Diactive‐1–Supported Progressive Resistance Training on Body Composition in Youth With Type 1 Diabetes. Journal of Cachexia, Sarcopenia and Muscle, 2026. DOI: 10.1002/jcsm.70257 PMID: 41854192.
• Soler-Lopez 2026. Standardized Program of Resistance Training for Prostate Cancer Patients Receiving Androgen Deprivation Therapy (SPoRT-PCa-ADT): study protocol for a randomized controlled trial. BMC Cancer, 2026. DOI: 10.1186/s12885-026-15902-w PMID: 42015017.
• Benali 2025. Efficacy of progressive resistance training intensities and adequate dietary protein intake for community-dwelling frail older adults (TEAMS study), protocol for a randomised controlled trial. BMC Geriatrics, 2025. DOI: 10.1186/s12877-025-06209-9 PMID: 40783689.
• Ucar 2025. Short-term resistance training enhances functional and physiological markers in older women: implications for biomechanical and health interventions in aging. Frontiers in Public Health, 2025. DOI: 10.3389/fpubh.2025.1630525 PMID: 40791617.
• Arroniz 2025. Effectiveness of Iso-Inertial Resistance Training on Muscle Power in Middle-Older Adults: Randomized Controlled Trial. JMIR Aging, 2025. DOI: 10.2196/66414 PMID: 40840466.
• Zhou 2025. Impacts of resistance training combined with vibration training on the IGF-1/PI3K/AKT/FOXO3 axis and clinical outcomes in patients with sarcopenia: A protocol for a randomized controlled trial. PLOS One, 2025. DOI: 10.1371/journal.pone.0333343 PMID: 41004429.
• Duan 2026. The effect of elastic-band resistance training on fecal microbiota and derived metabolites of aged individuals with possible sarcopenia. Frontiers in Medicine, 2026. DOI: 10.3389/fmed.2026.1762454 PMID: 41970373.
• Rosa 2026. Effect of resistance training combined with carbohydrate and protein supplementation on the HOMA-IR, glycemic, lipid profile and hypertrophy of older adults with Type II Diabetes: secondary data analysis of a triple-blind RCT. Aging Clinical and Experimental Research, 2026. DOI: 10.1007/s40520-026-03374-8 PMID: 41931150.
• Rosa 2025. Effects of Resistance Training Combined with Vitamin D Supplementation on Health-Related Variables in the Elderly: Muscle Strength, Body Composition, and Inflammatory Status. International Journal of Environmental Research and Public Health, 2025. DOI: 10.3390/ijerph22111695 PMID: 41302641.
• Chou 2025. Effects of synergistic tongue and chin resistance training on swallowing function, oral intake, and cognitive function in community-dwelling elderly individuals with frailty: a double-blind randomised controlled trial. Journal of Global Health, 2025. DOI: 10.7189/jogh.15.04358 PMID: 41346239.
• Channaoui 2025. Examining how resistance training affects bone strength in older adults with rheumatic diseases: a systematic review. BMC Rheumatology, 2025. DOI: 10.1186/s41927-025-00531-w PMID: 40598647.
• Thomson 2026. Understanding the gut microbiome through a fitness intervention of aerobic and resistance training for individuals with type 2 diabetes mellitus (GUTFIT: A Study Protocol). PLOS One, 2026. DOI: 10.1371/journal.pone.0343294 PMID: 41729946.
• PablosRodriguez 2026. Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review. Journal of Cachexia, Sarcopenia and Muscle, 2026. DOI: 10.1002/jcsm.70290 PMID: 42087380.
• Meng 2025. Effects of elastic band resistance training on lower limb strength and balance function in older adults: a systematic review and meta-analysis. Frontiers in Sports and Active Living, 2025. DOI: 10.3389/fspor.2025.1649305 PMID: 41278596.
• BenavidesRoca 2026. Association between cardiac autonomic control and blood pressure response to resistance training in adults with pharmacologically treated hypertension. Physiological Reports, 2026. DOI: 10.14814/phy2.70863 PMID: 41943475.
• Dardashtipour 2026. The effect of aerobic and resistance training in patients with type 2 diabetes on vitamin D (DIAVITEX): a study protocol. Frontiers in Public Health, 2026. DOI: 10.3389/fpubh.2025.1674293 PMID: 41561835.
• Shaw 2026. Arterial stiffness adaptations to chronic resistance and aerobic exercise: a systematic review of exercise modalities. Frontiers in Public Health, 2026. DOI: 10.3389/fpubh.2025.1701763 PMID: 41626383.
• Sanchez-Gonzalez 2026. A pilot randomized trial of supervised resistance training plus home-based activity in chronic lymphocytic leukaemia patients. Scientific Reports, 2026. DOI: 10.1038/s41598-026-38721-2 PMID: 41656287.
• Korman 2025. The feasibility of resistance training versus aerobic exercise in a rehabilitation setting for people living with psychotic disorders: A randomised controlled trial. The Australian and New Zealand Journal of Psychiatry, 2025. DOI: 10.1177/00048674251361681 PMID: 41215676.
• Xing 2026. Effects of low-load resistance training with blood flow restriction and swallowing training on sarcopenic dysphagia in community-dwelling older people in China: a randomised controlled trial protocol. BMC Geriatrics, 2026. DOI: 10.1186/s12877-026-07464-0 PMID: 41981492.
• Lai 2023. Dose–response effects of resistance training on physical function in frail older Chinese adults: A randomized controlled trial. Journal of Cachexia, Sarcopenia and Muscle, 2023. DOI: 10.1002/jcsm.13359 PMID: 37875291.
• Lv 2026. Additional treatment strategies for hypothyroidism: a network meta-analysis. Endocrine Connections, 2026. DOI: 10.1530/EC-26-0011 PMID: 41838451.
• Wang 2026b. Non-pharmacological interventions for improving sleep quality in adults aged 50 years and older: a systematic review and network meta-analysis. Archives of Public Health, 2026. DOI: 10.1186/s13690-026-01892-5 PMID: 41981687.
• CURRIER 2026. American College of Sports Medicine Position Stand. Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Medicine and Science in Sports and Exercise, 2026. DOI: 10.1249/MSS.0000000000003897 PMID: 41843416.
• Li 2026. The role of resistance training in improving beta-cell function in type 2 diabetes: a systematic review and meta-analysis. BMC Endocrine Disorders, 2026. DOI: 10.1186/s12902-026-02286-y PMID: 42050504.
• Ali 2026. Early Supervised Incremental Resistance Training Versus Standard Care Following Median Sternotomy—A Preliminary Analysis of a Randomized Controlled Trial. Interdisciplinary Cardiovascular and Thoracic Surgery, 2026. DOI: 10.1093/icvts/ivag085 PMID: 41863312.
• Benfica 2026. Effects of Remotely Supervised Home-Based High-Speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson Disease: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 2026. DOI: 10.2196/84689 PMID: 42082175.
• He 2026. The effects of Tai Chi Chuan combined with unstable resistance training on knee muscle strength and dynamic balance in female college students: a randomized controlled study protocol. Frontiers in Public Health, 2026. DOI: 10.3389/fpubh.2026.1868830 PMID: 42293609.
• Tian 2025. Comparison of the Effectiveness of Protein Supplementation Combined with Resistance Training on Body Composition and Physical Function in Healthy Elderly Adults. J Nutr, 2025. DOI: 10.1016/j.tjnut.2025.01.017 PMID: 39889852.
• Yu 2026. Comparative effects of different intensities of aerobic and resistance exercise on glycemic control and cardiorespiratory fitness in middle-aged older patients with type 2 diabetes: a network meta-analysis. Front Public Health, 2026. DOI: 10.3389/fpubh.2026.1818686 PMID: 42267276.
• Lander 2026. Resistance training partially restores age-related differences in skeletal muscle amino acid transporters - secondary analysis from two randomized controlled trials. J Nutr Health Aging, 2026. DOI: 10.1016/j.jnha.2026.100808 PMID: 41723912.
• Zhang 2026. The impact of resistance training on the Atherogenic index of plasma and cardiometabolic health-related indicators in middle-aged and older adults with type 2 diabetes: A systematic review and Meta-analysis. Maturitas, 2026. DOI: 10.1016/j.maturitas.2026.108935 PMID: 41950771.
• Wang 2025. Resistance training enhances metabolic and muscular health and reduces systemic inflammation in middle-aged and older adults with type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract, 2025. DOI: 10.1016/j.diabres.2025.112941 PMID: 41106502.
• Hsu 2026b. High-speed vs. low-speed resistance training on muscle function in individuals with low muscle mass and obesity. Exp Gerontol, 2026. DOI: 10.1016/j.exger.2026.113108 PMID: 41865846.
• Krok-Schoen 2026. Results of the E-intervention for Protein Intake and Resistance Training to Optimize Function (E-PROOF) study among older cancer survivors. J Geriatr Oncol, 2026. DOI: 10.1016/j.jgo.2026.102982 PMID: 42035739.

Background References

Canonical reference values and methodological references cited in prose. Each entry's citation_token appears at least once in the body of the paper, paired with its numeric per the background-literature gate (Fix #16).

• Perera 2006. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54(5):743-749. DOI: 10.1111/j.1532-5415.2006.00701.x PMID: 16696738.
• Ioannidis 2005. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124. (methodological reference) DOI: 10.1371/journal.pmed.0020124 PMID: 16060722.